{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:05:24Z","timestamp":1773752724711,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","award":["5-2014-B0001-00176"],"award-info":[{"award-number":["5-2014-B0001-00176"]}],"id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170362","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T13:56:25Z","timestamp":1485179785000},"page":"e0170362","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea"],"prefix":"10.1371","volume":"12","author":[{"given":"Hyo Jun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"A Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"ref2","first-page":"545","article-title":"Hepatitis B today","volume":"54","author":"M Safioleas","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"CJ Chen","year":"2006","journal-title":"Jama"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"UH Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/hep.24318","article-title":"Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice","volume":"53","author":"C Hongthanakorn","year":"2011","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"YF Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10620-014-3486-7","article-title":"Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection","volume":"60","author":"M Buti","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.02600-12","article-title":"Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside\/nucleotide analogue-naive patients with chronic hepatitis B","volume":"57","author":"B Baran","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"F van Bommel","year":"2010","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2013.11.024","article-title":"Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients","volume":"60","author":"T Berg","year":"2014","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3851\/IMP2481","article-title":"Long-term therapy with nucleoside\/nucleotide analogues for chronic hepatitis B in Asian patients","volume":"18","author":"CQ Pan","year":"2013","journal-title":"Antivir Ther"},{"key":"ref13","article-title":"Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany","author":"J Petersen","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref14","article-title":"Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France","author":"P Marcellin","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3350\/cmh.2014.20.3.261","article-title":"Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort","volume":"20","author":"SS Ahn","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3350\/cmh.2015.21.1.41","article-title":"Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naive and nucleos(t)ide analogue-experienced chronic hepatitis B patients","volume":"21","author":"SK Jung","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s11096-015-0193-1","article-title":"Efficacy and safety of tenofovir in nucleos(t)ide-naive patients with genotype C chronic hepatitis B in real-life practice","volume":"37","author":"JH Kim","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e2400","DOI":"10.1097\/MD.0000000000002400","article-title":"Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents","volume":"95","author":"JH Shin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.23044","article-title":"Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil","volume":"50","author":"NB Ha","year":"2009","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/hep.27730","article-title":"Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection","volume":"62","author":"HS Hwang","year":"2015","journal-title":"Hepatology"},{"key":"ref21","article-title":"Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naive and -experienced chronic hepatitis B patients","author":"HM Wang","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e89789","DOI":"10.1371\/journal.pone.0089789","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings","volume":"9","author":"CQ Pan","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","article-title":"Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B","volume":"140","author":"EJ Heathcote","year":"2011","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2013.12.028","article-title":"Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B","volume":"146","author":"S Fung","year":"2014","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/jmv.24201","article-title":"Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance","volume":"87","author":"HJ Cho","year":"2015","journal-title":"J Med Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.clinthera.2015.04.007","article-title":"Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination","volume":"37","author":"JH Park","year":"2015","journal-title":"Clin Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3748\/wjg.v21.i9.2746","article-title":"Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients","volume":"21","author":"DH Yang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2893.2011.01533.x","article-title":"Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir","volume":"19","author":"CQ Pan","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref29","article-title":"Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial","author":"YS Lim","year":"2015","journal-title":"Gut"},{"key":"ref30","article-title":"Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial","author":"YS Lim","year":"2015","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2010.223206","article-title":"Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B","volume":"60","author":"SJ Patterson","year":"2011","journal-title":"Gut"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/AAC.03845-14","article-title":"Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains","volume":"58","author":"YB Lee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3904\/kjim.2015.30.1.32","article-title":"Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients","volume":"30","author":"HJ Kim","year":"2015","journal-title":"Korean J Intern Med"},{"key":"ref34","article-title":"Entecavir Plus Tenofovir Combination Therapy in Patients with Multi-drug Resistant Chronic Hepatitis B: Results of A Multicenter, Prospective Study","author":"JY Park","year":"2016","journal-title":"Liver Int"},{"key":"ref35","article-title":"Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B","author":"S Lee","year":"2015","journal-title":"J Med Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3346\/jkms.2005.20.5.816","article-title":"Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea","volume":"20","author":"SH Bae","year":"2005","journal-title":"J Korean Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:50:27Z","timestamp":1588960227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170362"}},"subtitle":[],"editor":[{"given":"Haitao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170362","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]}}}